EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multidimensional biomarkers for systemic diseases: A narrative review on the implications of growth differentiation factor 15 for neurological health and beyond

Durlav Chowdhury, Navya P, Arunava Mishra, Geetanjali Darsena, Surendra H. Bodakhe

NeuroMarkers · 2026-11 · 100254

DOI: 10.1016/j.neumar.2026.100254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NeuroMarkers, 2026-11. Verfasst von Durlav Chowdhury und 4 weiteren Autor:innen. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growth differentiation factor 15 is a unique cytokine that responds to stress and is part of the transforming growth factor-β superfamily. It serves as a commonly used biomarker because of its involvement in macrophage activation and tissue damage, reflecting various pathological and physiological states in systemic cellular stress and circulation levels. This comprehensive review critically evaluates the ubiquitous presence and prognostic value of growth differentiation factor 15 in conditions such as metabolic disorders (including diabetes and metabolic syndrome), liver and kidney diseases, and cardiovascular pathologies. In these conditions, elevated levels consistently correlate with disease severity and mortality risk. Additionally, we synthesize current findings on its complex role in cancer pathogenesis, autoimmune dysregulation, and respiratory illnesses. Given the known impact of systemic inflammation and cellular stress on neurological function, we explore the emerging evidence of the mechanistic links of growth differentiation factor 15 in neurodegenerative conditions, neuroinflammation, and stroke. This review details the diverse clinical applications and biological functions of growth differentiation factor 15 to highlight its profound connection to major global health concerns. Particular emphasis is placed on its burgeoning role as a powerful diagnostic and prognostic biomarker.

Zitieren

APA

Chowdhury, D., P, N., Mishra, A., Darsena, G., & Bodakhe, S. H. (2026). Multidimensional biomarkers for systemic diseases: A narrative review on the implications of growth differentiation factor 15 for neurological health and beyond. NeuroMarkers, 100254. https://doi.org/10.1016/j.neumar.2026.100254

Vancouver

Chowdhury D, P N, Mishra A, Darsena G, Bodakhe SH. Multidimensional biomarkers for systemic diseases: A narrative review on the implications of growth differentiation factor 15 for neurological health and beyond. NeuroMarkers. 2026:100254. doi:10.1016/j.neumar.2026.100254

BibTeX
@article{Chowdhury2026,
  author = {Chowdhury, Durlav and P, Navya and Mishra, Arunava and Darsena, Geetanjali and Bodakhe, Surendra H.},
  title = {Multidimensional biomarkers for systemic diseases: A narrative review on the implications of growth differentiation factor 15 for neurological health and beyond},
  journal = {NeuroMarkers},
  year = {2026},
  pages = {100254},
  doi = {10.1016/j.neumar.2026.100254}
}
Kostenlos starten →